Rybelsus is a new pill-form drug for treating Type 2 diabetes containing semaglutide – the same substance as in Ozempic.  Rybelsus is an oral tablet version of semaglutide taken daily. Ozempic is an injectable form of the same medication taken once each week.  Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist. GLP-1 is a hormone produced in the gut. It is released in response to food, prompting the release of insulin and a reduction in appetite.  In the case of people with Type 2 diabetes, semaglutide works to slow down digestion. This stimulates the increased production of natural insulin. Rybelsus doesn’t work like other treatments of diabetes, that boost insulin levels from external sources (injection or oral insulin).  If you have been diagnosed as clinically obese, your doctor may prescribe Rybelsus as a weight-loss treatment along with appropriate diet controls and exercise. The primary effect of Rybelsus in this mode is as an appetite suppressant.